Artivion | CRY - Assets


Artivion reported $1.07B in Assets for its fiscal quarter ending in June of 2026.





Assets Change Date
Abbott USD 110.43B 23.72B Mar/2026
Accuray USD 448.01M 8.81M Dec/2025
AngioDynamics USD 269.68M 4.04M Sep/2025
Artivion USD 1.07B 188.78M Jun/2026
AtriCure USD 676.64M 32.66M Jun/2026
Baxter International USD 19.79B 55M Jun/2026
Becton, Dickinson and Co. USD 50.73B 101M Jun/2026
Boston Scientific USD 45.22B 865M Jun/2026
Edwards Lifesciences USD 13.87B 545.9M Jun/2026
Inogen USD 307.01M 5.03M Sep/2025
Integra LifeSciences USD 3.56B 14.24M Jun/2026
J&J USD 201.06B 167M Jun/2026
Mesa Laboratories USD 434.85M 4.5M Dec/2025
Orthofix International USD 873.02M 13.58M Jun/2026
Pfizer USD 201.13B 6.49B Jun/2026
ResMed USD 8.97B 181.66M Jun/2026
Stryker USD 47.93B 1.64B Jun/2026
Tandem Diabetes Care USD 1.15B 808K Jun/2026
Teleflex USD 6.79B 3.78M Jun/2026
Terumo JPY 2.37T 61.86B Jun/2026
Trinity Biotech USD 105.16M 1.45M Dec/2025